Industry news

A DNA nanorobot is programmed to pick up and sort molecules into predefined regions.

The Laboratory of Hybrid Biomaterials of Tomsk Polytechnic University invites TPU students, including international ones, as well as master students and postgraduates for research collaboration.

AstraZeneca, an international biopharmaceutical company, launched a new high-tech manufacturing process at its plant in Vorsino industrial park of Kaluga region. One of the first medicines to be produced on a new line will be osimertinib, an innovative targeted agent for the treatment of lung cancer.

Insys Therapeutics already has former executives under indictment as it faces numerous investigations and lawsuits. Now, a new congressional report details some sales techniques by former employees at the company for powerful painkiller Subsys as the United States grapples with a deadly addiction epidemic.

n September 2016, routine screening of a female infant aged 9 months in Manchester, Connecticut, showed normocytic anemia and a blood lead level of 41 μg/dL (levels exceeding 5 μg/dL are abnormal).

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

Chiropractic, homeopathy, acupuncture, juice diets, and other forms of unproven alternative medicine cannot cure cancer, no matter what some quacks might claim. Unfortunately, vulnerable cancer patients turn to these charlatans every year rather than visit real doctors, hoping for a miracle treatment to purge them of their monstrous disease.

Pancreatic cancer has one of the worst prognoses — with a five-year survival rate of 9 percent — in part because there are no telltale symptoms or non-invasive screening tools to catch a tumor before it spreads.